Merck Is Partnering With America’s Largest HBCU To Launch a Collaborative Biotechnology Learning Center

June 20, 2024 10:15 AM

NORTHAMPTON, MA / ACCESSWIRE / June 20, 2024 / Building the workforce of tomorrow means investing in the students of today. That's why Merck has partnered with North Carolina Agricultural and Technical State University (N.C. A&T) - the largest historically Black college and university in the U.S. - to launch the Merck Biotechnology Learning Center."We're pleased to launch this new collaboration with an institution that precisely aligns to our...

Read more

The Siegel Rare Neuroimmune Association Creates First-Ever Online Micro-Course for People With Rare Neuroimmune Disorders

June 20, 2024 9:30 AM

The online learning program reflects organization's dedication to empowering individuals and families affected by these conditions with knowledge and supportPOWELL, OH / ACCESSWIRE / June 20, 2024 / The Siegel Rare Neuroimmune Association (SRNA) has released several new courses as part of its unique online learning program. This innovative educational series provides a comprehensive understanding of rare neuroimmune disorders. Every course...

Read more

Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

June 20, 2024 9:15 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, and Alphazyme LLC (Alphazyme), a Maravai LifeSciences company (NASDAQ:MRVI) and global provider of specialty enzymes used in the life sciences sector, announced the successful conclusion of the companies' previously announced Linea™ RNAP manufacturing scale-up agreement. The joint process development project resulted in an over 70% reduction in Linea...

Read more

Catheter Precision, Inc. Announces Receipt of First Purchase Order for VIVO from Distributor in Middle East

June 20, 2024 8:00 AM

Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a US based innovative medical device company announced that it has received its first purchase order from Qatar. As previously announced, an initial evaluation of the VIVO product was completed earlier this year at Hamad Medical Corporation Heart Hospital in Doha."VIVO is a tool that allows physicians to streamline ventricular ablation procedures potentially saving time and reducing...

Read more

Rutherrin(R) Repurposes Non-Cancer Drugs for Cancer Therapy

June 20, 2024 7:00 AM

Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that in preclinical research, it's lead drug formulation, Rutherrin® was able to repurpose...

Read more

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

June 20, 2024 7:00 AM

ORLANDO, FL / ACCESSWIRE / June 20, 2024 / Nutriband Inc.("Company") (NASDAQ:NTRB)(NASDAQ:NTRBW) provides an update on its Aversa Fentanyl product development program to shareholders as it aims to complete scale-up of the commercial manufacturing process and move towards the single Phase 1 human abuse potential study prior to NDA filing.As previously reported, the Company with its partner Kindeva Drug Delivery completed the feasibility agreement...

Read more

A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model

June 20, 2024 6:30 AM

NanoViricides, Inc. (NYSE AmerIcan.:NNVC) (the "Company"), a clinical stage company and global leader in broad-spectrum antiviral nanomedicines, reports that the ultra-broad-spectrum antiviral NV-387, a clinical Phase II stage drug candidate, was found to be effective in protecting lungs from damage in a lethally infected Influenza A H3N2 mouse model."We believe that the lung protection afforded by NV-387 is a very important result. The most...

Read more

MindBio Therapeutics Reports Sustained Antidepressant Response from MB22001 in Depression Clinical Trials

June 20, 2024 6:10 AM

MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), a leading biopharmaceutical company in psychiatric medicine development, is delighted to report durability data from Phase 2A clinical trials in depressed patients testing MB22001, MindBio's proprietary self-administered take home microdose of Lysergic Acid Diethylamide (LSD). We are pleased to report a significant and sustained antidepressant response in patient...

Read more

Enraf-Nonius Partners with Kismet Holdings Group to Bring an Unmatched Selection of Elite Rehabilitation and Recovery Modalities to the U.S.

June 20, 2024 5:00 AM

Enraf-Nonius, a global market leader in rehabilitation and physiotherapy equipment, is expanding its premier technology portfolio to the U.S. for the first time in its 100-year history. An official launch will occur at the National Athletic Trainers Association AT Expo in New Orleans, LA, beginning June 26th. Its debut will feature the widest selection of rehabilitation modalities ever offered in North America - state-of-the-art Magnetic, Tecar,...

Read more

Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders

June 20, 2024 2:20 AM

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / June 20, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo Germany AG. Novartis BidCo Germany AG proposed to enter negotiations with the MorphoSys AG Management Board on a merger agreement.In connection with the merger of MorphoSys AG into...

Read more

Cantargia presents Phase 2 Clinical Data in Pancreatic Cancer with Nadunolimab at ESMO Gastrointestinal Cancer Congress 2024

June 20, 2024 1:20 AM

LUND, SE / ACCESSWIRE / June 20, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today announced that nadunolimab (CAN04) combination therapy results in advanced/metastatic pancreatic cancer (PDAC) will be presented at ESMO Gastrointestinal Cancer Congress 2024 in Munich June 26-29. Efficacy in the 73 patients treated was better than expected for chemotherapy only based on historical data. Strongest efficacy was...

Read more

Biophytis Extends Its Contract With Atlas to Secure Financing for Its Business Activities

June 19, 2024 7:50 PM

Important note: Biophytis has set up financing in the form of Bonds redeemable in cash and in new and existing shares (ORNANE) with the company Atlas, which, after having received the shares resulting from the conversion or exercise of these instruments, is not intended to remain a shareholder of the company. The shares resulting from the conversion of the above-mentioned securities will, in general, be sold on the market very quickly, which may...

Read more

BioNxt Solutions Announces Closing of Second Tranche of Non-Brokered Private Placement

June 19, 2024 7:00 PM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT) is pleased to announce that, further to its news releases dated April 25, 2024, and May 10, 2024, the Company has closed the second tranche of its non-brokered private placement in the amount of 1,000,000 common shares in the capital of the Company (each, a "Common Share") at a price of $0.27 per Common Share for gross proceeds of $270,000 (the "Second Tranche")....

Read more

MediOrbis(TM) Partners with Healthyr(TM) to Offer Proven Engagement, Longitudinal Care and Specialty

June 19, 2024 1:10 PM

MediOrbis, a multi-specialty digital health company with comprehensive specialty telemedicine services and chronic disease management programs, is partnering with Healthyr to offer proprietary engagement, monitoring and early detection services as a part of a comprehensive telehealth platform. Effective immediately, clients can now access these industry-leading programs as a means of enhancing outcomes in complex and chronic specialty...

Read more

Humhealth Simplifies the Medicare Program With All-in-One Software

June 19, 2024 1:00 PM

WIXOM, MI / ACCESSWIRE / June 19, 2024 / Humhealth has emerged as a software provider to consolidate multiple software solutions into a single software package. Humhealth is a unified platform that streamlines critical software services for Chronic Care Management (CCM), Remote Patient Monitoring (RPM), Annual Wellness Visit (AWV), Behavioral Health Integration (BHI), Chronic Pain Management (CPM), Remote Therapeutic Monitoring (RTM) and...

Read more

United Global Trading Corp. Announces ShieldON(R) EcoSeries Biodegradable Nitrile Gloves

June 19, 2024 12:30 PM

FDA-Approved Single-Use Nitrile Gloves Break Down Faster Than Conventional GlovesLONG BEACH, CA / ACCESSWIRE / June 19, 2024 / Recognizing the rising need for a sustainable nitrile glove solution, United Global Trading Corp. announces the launch of biodegradable nitrile gloves: ShieldON® EcoSeries. Featuring EcoBlue, EcoGreen, and EcoBlack, this innovative product line is designed to address the pressing environmental concerns associated with...

Read more

Xironetic Appoints Jeff Potts to Chief Technology Officer

June 19, 2024 12:00 PM

OKLAHOMA CITY, OK / ACCESSWIRE / June 19, 2024 / Xironetic, a provider of augmented reality surgical guidance technology, is announcing the appointment of Jeff Potts to Chief Technology Officer.Xironetic logo "I am thrilled to announce Jeff's selection to the role of CTO as our company sees rapidly increasing clinical adoption by surgeons at leading healthcare institutions across the globe," said Dr. Christian El-Amm, Founder and Executive...

Read more

New Avenues Rehab Center in Virginia Offers Hope and Healing

June 19, 2024 10:00 AM

Avenues Recovery Center Opening in Norfolk Will Change the Landscape of Mental Health Care in VirginiaNORFOLK, VA / ACCESSWIRE / June 19, 2024 / In response to the growing need for comprehensive addiction treatment services, Avenues Recovery Center announces the grand opening of its brand-new residential treatment center in Norfolk, Virginia. This facility is set to revolutionize addiction recovery in the region by merging highly targeted...

Read more

Gilead and Kite Pharma Celebrates Pride Month

June 19, 2024 9:15 AM

NORTHAMPTON, MA / ACCESSWIRE / June 19, 2024 / Gilead SciencesGilead and Kite Pharma teams raised Pride Month flags at our campuses last week symbolizing our united support for LGBTQ+ communities globally. Our commitment to inclusion and diversity is vital to our mission and will help us create a healthier world for all people.Gilead SciencesGilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and...

Read more

For Pride Month, Mental Health Professionals Offer Parenting Help

June 19, 2024 9:00 AM

Parenting is a hard job under the best of circumstances. It can be especially confusing if that parent is unfamiliar or uncomfortable with the world of LGTBQIA+ and their child is asking questions they feel unprepared to address. On June 27, a panel of legitimate professionals will allow parents to anonymously ask their most concerning questions in real time.APEX, NC / ACCESSWIRE / June 19, 2024 / A local mental health practice will soon give...

Read more